British Embassy, DIT and BritCham in Vietnam – UK Export Win – AstraZeneca Vietnam


The British Embassy, DIT and BritCham in Vietnam have provided AstraZeneca Vietnam with tremendous support in securing high-level government engagement and advocating for favorable pharmaceutical law and regulations, playing a vital role in the company’s long-term and sustainable growth.  

With their support, AstraZeneca Vietnam Company Limited successfully obtained the FIE licence for import, export and clinical trials, as well as officially inaugurated in July 2020 as a local entity and signed a landmark distribution partnership with a major local distributor – Phytopharma. As a result, UK export will be boosted. 

The following data is of AstraZeneca’s export forecast from the United Kingdom for AstraZeneca Vietnam FIE (USD): 22.9m in 2020, 36.2m in 2021, 59m in 2022 and 59.1m in 2023.

UK Export Win to Vietnam


FY 21

FY 22


AstraZeneca Vietnam Company Limited





Disclaimer: The forecast will be updated from time to time based on market development.

In addition, BritCham platform has provided various invaluable opportunities for AstraZeneca to engage with high-level government leaders. Notable was the “Meet the UK” event in November 2019 co-hosted by Vietnam Ministry of Foreign Affairs (MOFA) and British Embassy where AstraZeneca had the chance to connect with and present on stage to 700 ministerial and provincial leaders from across Vietnam. BritCham also arranged a joint workshop with the British Embassy and MOFA to enhance capacity building in digital transformation for provincial leaders. At this event, AstraZeneca Vietnam was invited to present on innovation and digital health.

With much thanks to the British Embassy, DIT and BritCham, AstraZeneca Vietnam continues to maintain our leadership position in the pharma sector, improve Vietnam’s healthcare system, and contribute to UK-Vietnam trade relations through increased UK export wins.  


Premium Airline Sponsors

In-kind Silver










Share this on: